BDBM143326 US8940893, 11
SMILES: Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cn3)c12)C1CC2(C1)CN(C2)C(=O)C=C
InChI Key: InChIKey=ZJFVKWGIIOZKBD-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine-protein kinase BTK (Homo sapiens (Human)) | BDBM143326 (US8940893, 11) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description An HTRF assay (Cisbio KinEASE-TK cat #62TKOPEC) was performed to quantitate the ability of test compounds to inhibit BTK mediated phosphorylation of ... | US Patent US8940893 (2015) BindingDB Entry DOI: 10.7270/Q2PV6J3P | |||||||||||
More data for this Ligand-Target Pair |